サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：疫学向け人工知能の世界市場の規模：展開別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測（2022年～2030年）
市場調査レポート
商品コード
1132569

疫学向け人工知能の世界市場の規模：展開別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測（2022年～2030年）

Artificial Intelligence in Epidemiology Market Size By Deployment, By Application, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 195 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
疫学向け人工知能の世界市場の規模：展開別、用途別、最終用途別、業界分析、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測（2022年～2030年）
出版日: 2022年09月29日
発行: Global Market Insights Inc.
ページ情報: 英文 195 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の疫学向け人工知能の市場規模は、深層学習や機械学習、予測分析、その他の革新的な技術の進歩により、2022年～2030年に大きく成長すると予測されています。

当レポートでは、世界の疫学向け人工知能市場について調査分析し、業界の考察、セグメント分析、地域分析、競合情勢などを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 疫学向け人工知能：業界の考察

  • 業界セグメンテーション
  • 業界情勢（2017年～2030年）
  • 業界の影響要因
    • 成長促進要因
    • 業界の潜在的リスク・課題
  • 成長可能性分析
    • 展開別
    • 用途別
    • 最終用途別
  • COVID-19の影響の分析
  • 規制情勢
    • 米国
    • 欧州
    • 中国
    • その他
  • 償還シナリオ
    • 米国
    • 欧州
  • ギャップ分析
  • スタートアップシナリオ
  • 投資情勢
  • 政策情勢
    • H-480.940 - 医療における拡張知能
    • FDAのデジタルヘルスイニシアチブ
  • 技術情勢
  • 応用可能性
    • 公衆衛生（疾病監視）
    • 創薬・開発
  • ポーターのファイブフォース分析
  • 競合情勢（2021年）
    • 企業マトリックス分析（2021年）
  • PESTLE分析

第4章 疫学向け人工知能市場：展開別

  • 主なセグメントの動向
  • オンプレミス
  • ウェブベース
  • クラウドベース

第5章 疫学向け人工知能市場：用途別

  • 主なセグメントの動向
  • 感染の予想と予測
  • 疾病と症候群の監視
  • 人々の健康と発生率/有病率の監視

第6章 疫学向け人工知能市場：最終用途別

  • 主なセグメントの動向
  • 政府と州の機関
  • 研究所
  • 製薬企業・バイオテクノロジー企業
  • 医療提供者

第7章 疫学向け人工知能市場：地域別

  • 主な地域の動向
  • 北米
    • 市場規模：国別（2017年～2030年）
    • 市場規模：展開別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • 米国
    • カナダ
  • 欧州
    • 市場規模：国別（2017年～2030年）
    • 市場規模：展開別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 市場規模：国別（2017年～2030年）
    • 市場規模：展開別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • 市場規模：国別（2017年～2030年）
    • 市場規模：展開別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 市場規模：国別（2017年～2030年）
    • 市場規模：展開別（2017年～2030年）
    • 市場規模：用途別（2017年～2030年）
    • 市場規模：最終用途別（2017年～2030年）
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 企業プロファイル

  • 競合ダッシュボード（2021年）
  • Cerner Corporation
  • Cognizant
  • eClinicalWorks, Inc.
  • Epic Systems Corporation
  • Alphabet, Inc.
  • Intel Corporation
  • Microsoft Corporation
  • Meditech
  • Predixion Healthcare (Jvion LLC)
  • Komodo Health
  • Siemens Healthineers
  • Bayer Healthcare
  • Cardiolyse
  • Artificial Intelligence in Medical Epidemiology (AIME)
  • SAS Institute
図表

Data Tables

  • TABLE 1. Global Artificial Intelligence in epidemiology, 2017 - 2021 (USD Million)
  • TABLE 2. Global Artificial Intelligence in epidemiology, 2022 - 2030 (USD Million)
  • TABLE 3. Global Artificial Intelligence in epidemiology, by deployment, 2017 - 2021 (USD Million)
  • TABLE 4. Global Artificial Intelligence in epidemiology, by deployment, 2022 - 2030 (USD Million)
  • TABLE 5. Global Artificial Intelligence in epidemiology, by application, 2017 - 2021 (USD Million)
  • TABLE 6. Global Artificial Intelligence in epidemiology, by application, 2022 - 2030 (USD Million)
  • TABLE 7. Global Artificial Intelligence in epidemiology, by end-use, 2017 - 2021 (USD Million)
  • TABLE 8. Global Artificial Intelligence in epidemiology, by end-use, 2022 - 2030 (USD Million)
  • TABLE 9. Global Artificial Intelligence in epidemiology, by region, 2017 - 2021 (USD Million)
  • TABLE 10. Global Artificial Intelligence in epidemiology, by region, 2022 - 2030 (USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Cloud-based market size, by region, 2017 - 2021 (USD Million)
  • TABLE 13. Cloud-based market size, by region, 2022 - 2030 (USD Million)
  • TABLE 14. Web-based market size, by region, 2017 - 2021 (USD Million)
  • TABLE 15. Web-based market size, by region, 2022 - 2030 (USD Million)
  • TABLE 16. Infection prediction and forecasting market size, by region, 2017 - 2021 (USD Million)
  • TABLE 17. Infection prediction and forecasting market size, by region, 2022 - 2030 (USD Million)
  • TABLE 18. Disease and syndromic surveillance market size, by region, 2017 - 2021 (USD Million)
  • TABLE 19. Disease and syndromic surveillance market size, by region, 2022 - 2030 (USD Million)
  • TABLE 20. Government and state agencies market size, by region, 2017 - 2021 (USD Million)
  • TABLE 21. Government and state agencies market size, by region, 2022 - 2030 (USD Million)
  • TABLE 22. Research labs market size, by region, 2017 - 2021 (USD Million)
  • TABLE 23. Research labs market size, by region, 2022 - 2030 (USD Million)
  • TABLE 24. Pharmaceutical and biotechnology companies market size, by region, 2017 - 2021 (USD Million)
  • TABLE 25. Pharmaceutical and biotechnology companies market size, by region, 2022 - 2030 (USD Million)
  • TABLE 26. Healthcare providers market size, by region, 2017 - 2021 (USD Million)
  • TABLE 27. Healthcare providers market size, by region, 2022 - 2030 (USD Million)
  • TABLE 28. North America Artificial Intelligence in epidemiology size, by country, 2017 - 2021 (USD Million)
  • TABLE 29. North America Artificial Intelligence in epidemiology size, by country, 2022 - 2030 (USD Million)
  • TABLE 30. North America Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 31. North America Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 32. North America Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 33. North America Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 34. North America Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 35. North America Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 36. U.S. Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 37. U.S. Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 38. U.S. Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 39. U.S. Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 40. U.S. Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 41. U.S. Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 42. Canada Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 43. Canada Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 44. Canada Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 45. Canada Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 46. Canada Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 47. Canada Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 48. Europe Artificial Intelligence in epidemiology size, by country, 2017 - 2021 (USD Million)
  • TABLE 49. Europe Artificial Intelligence in epidemiology size, by country, 2022 - 2030 (USD Million)
  • TABLE 50. Europe Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 51. Europe Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 52. Europe Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 53. Europe Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 54. Europe Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 55. Europe Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 56. Germany Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 57. Germany Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 58. Germany Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 59. Germany Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 60. Germany Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 61. Germany Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 62. UK Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 63. UK Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 64. UK Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 65. UK Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 66. UK Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 67. UK Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 68. France Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 69. France Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 70. France Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 71. France Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 72. France Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 73. France Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 74. Spain Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 75. Spain Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 76. Spain Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 77. Spain Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 78. Spain Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 79. Spain Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 80. Italy Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 81. Italy Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 82. Italy Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 83. Italy Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 84. Italy Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 85. Italy Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 86. Asia Pacific Artificial Intelligence in epidemiology size, by country, 2017 - 2021 (USD Million)
  • TABLE 87. Asia Pacific Artificial Intelligence in epidemiology size, by country, 2022 - 2030 (USD Million)
  • TABLE 88. Asia Pacific Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 89. Asia Pacific Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 90. Asia Pacific Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 91. Asia Pacific Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 92. Asia Pacific Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 93. Asia Pacific Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 94. China Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 95. China Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 96. China Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 97. China Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 98. China Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 99. China Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 100. Japan Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 101. Japan Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 102. Japan Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 103. Japan Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 104. Japan Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 105. Japan Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 106. India Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 107. India Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 108. India Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 109. India Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 110. India Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 111. India Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 112. Australia Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 113. Australia Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 114. Australia Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 115. Australia Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 116. Australia Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 117. Australia Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 118. South Korea Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 119. South Korea Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 120. South Korea Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 121. South Korea Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 122. South Korea Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 123. South Korea Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 124. Taiwan Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 125. Taiwan Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 126. Taiwan Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 127. Taiwan Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 128. Taiwan Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 129. Taiwan Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 130. Latin America Artificial Intelligence in epidemiology size, by country, 2017 - 2021 (USD Million)
  • TABLE 131. Latin America Artificial Intelligence in epidemiology size, by country, 2022 - 2030 (USD Million)
  • TABLE 132. Latin America Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 133. Latin America Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 134. Latin America Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 135. Latin America Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 136. Latin America Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 137. Latin America Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 138. Brazil Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 139. Brazil Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 140. Brazil Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 141. Brazil Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 142. Brazil Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 143. Brazil Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 144. Mexico Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 145. Mexico Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 146. Mexico Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 147. Mexico Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 148. Mexico Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 149. Mexico Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 150. Argentina Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 151. Argentina Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 152. Argentina Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 153. Argentina Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 154. Argentina Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 155. Argentina Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 156. MEA Artificial Intelligence in epidemiology size, by country, 2017 - 2021 (USD Million)
  • TABLE 157. MEA Artificial Intelligence in epidemiology size, by country, 2022 - 2030 (USD Million)
  • TABLE 158. MEA Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 159. MEA Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 160. MEA Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 161. MEA Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 162. MEA Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 163. MEA Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 164. South Africa Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 165. South Africa Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 166. South Africa Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 167. South Africa Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 168. South Africa Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 169. South Africa Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 170. Saudi Arabia Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 171. Saudi Arabia Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 172. Saudi Arabia Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 173. Saudi Arabia Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 174. Saudi Arabia Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 175. Saudi Arabia Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 176. Israel Artificial Intelligence in epidemiology size, by deployment, 2017 - 2021 (USD Million)
  • TABLE 177. Israel Artificial Intelligence in epidemiology size, by deployment, 2022 - 2030 (USD Million)
  • TABLE 178. Israel Artificial Intelligence in epidemiology size, by application, 2017 - 2021 (USD Million)
  • TABLE 179. Israel Artificial Intelligence in epidemiology size, by application, 2022 - 2030 (USD Million)
  • TABLE 180. Israel Artificial Intelligence in epidemiology size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 181. Israel Artificial Intelligence in epidemiology size, by end-use, 2022 - 2030 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Artificial Intelligence in epidemiology industry 360 degree synopsis, 2017 - 2030
  • FIG. 4 Industry segmentation
  • FIG. 5 Global Artificial Intelligence in epidemiology, 2017 - 2030 (USD Million)
  • FIG. 6 Growth potential analysis, by deployment
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Growth potential analysis, by end-use
  • FIG. 9 Gap analysis
  • FIG. 10 Porter's analysis
  • FIG. 11 Company matrix analysis, 2021
  • FIG. 12 PESTEL analysis
  • FIG. 13 Key segment trends, by deployment
  • FIG. 14 Key segment trends, by application
  • FIG. 15 Key segment trends, by end-use
  • FIG. 16 Key regional trends
  • FIG. 17 Strategy dashboard, 2021
目次
Product Code: 5364

The global artificial intelligence in epidemiology market size is projected to grow substantially over 2022-2030, given the advancement in deep learning, machine learning, predictive analytics, and other innovative technologies.

During drug discovery, a potential candidate can be selected from millions of molecules. A prediction error of at least 1% may lead to the misidentification of over 10,000 molecules. Emphasis on improving the accuracy of machine learning models has therefore risen, which is likely to result in the escalating usage of AI in epidemiology.

With the high burden of chronic diseases, the need for the implementation of effective control measures and the development of effective treatment options has also increased. Based on data from the Centers for Disease Control and Prevention, over 1.7 million people are diagnosed with cancer every year. As a result, the use of advanced technologies including AI in cancer epidemiology applications is expected to witness an upsurge worldwide.

Artificial intelligence in epidemiology industry is segregated in terms of deployment, application, end-use, and region.

Based on deployment, the industry share from the cloud-based segment is set to depict a considerable growth rate through 2030, driven by the rising emphasis on leveraging the benefits of IT infrastructures, mainly during the COVID-19 pandemic.

Healthcare sectors are working to improve privacy, lower expenses, and enhance patient care through remote collaboration and monitoring. These trends will increase the application scope of cloud computing in the healthcare sector to store a huge amount of data and consequently proliferate the adoption of AI technology in epidemiological applications.

With regards to the application spectrum, the infection prediction and forecasting segment is anticipated to register commendable revenue over the estimated timeline. This is credited to the high exposure to new pathogens and the rise of epidemics and pandemics.

The evolution of microbes has also augmented the rate of infectious disease outbreaks globally, which may promote the use of artificial intelligence in epidemiology labs to predict and forecast new infections.

In terms of end-use, the pharmaceutical and biotechnology companies segment is slated to attain a valuation of more than USD 1.3 billion by 2030, given the mounting investment in drug discovery and the escalation of effective drug development initiatives. The adoption of the AI-first approach has also led to increased drug discovery and trial, which is generating opportunities for artificial intelligence in epidemiology industry growth.

From a regional frame of reference, the Middle East and Africa (MEA) region is likely to hold a major share of the artificial intelligence in epidemiology market by 2030. The number of elderly people is growing, which may have a significant impact on healthcare systems due to the increased disease burden. Healthcare infrastructure has also remained robust in countries including the UAE, augmenting the usage of advanced tech including AI for epidemiological surveillance in the healthcare sector.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Artificial Intelligence in epidemiology industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Deployment trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Artificial Intelligence In Epidemiology Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising adoption of artificial intelligence in epidemiology & disease surveillance
      • 3.3.1.2 Potential to increase quality of care delivery
      • 3.3.1.3 Need to curb incremental healthcare costs
      • 3.3.1.4 Advancements in Machine Learning, Deep Learning, and Predictive Analytics
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Security concerns regarding patient data
      • 3.3.2.2 Data availability and quality challenges
  • 3.4 Growth potential analysis
    • 3.4.1 By deployment
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 COVID- 19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
      • 3.6.1.1 Health IT Legislation
      • 3.6.1.2 Health Information Technology for Economic and Clinical Health (HITECH) Act
      • 3.6.1.3 HIPAA
      • 3.6.1.4 Health IT Regulations
      • 3.6.1.5 Common Rule
      • 3.6.1.6 Federal Trade Commission Act (FTCA)
      • 3.6.1.7 FTC Health Breach Notification Rule
    • 3.6.2 Europe
    • 3.6.3 China
    • 3.6.4 Others
  • 3.7 Reimbursement scenario
    • 3.7.1 U.S.
    • 3.7.2 Europe
  • 3.8 Gap analysis
  • 3.9 Start-up scenario
  • 3.10 Investment landscape
  • 3.11 Policy landscape
    • 3.11.1 H-480.940- Augmented Intelligence in Health Care
    • 3.11.2 FDA's Digital Health Initiative
  • 3.12 Technology landscape
  • 3.13 Application potential
    • 3.13.1 Public health (Disease Surveillance)
    • 3.13.2 Drug Discovery & Development
  • 3.14 Porter's Analysis
  • 3.15 Competitive landscape, 2021
    • 3.15.1 Company matrix analysis, 2021
  • 3.16 PESTLE Analysis

Chapter 4 Artificial Intelligence In Epidemiology Market, By Deployment

  • 4.1 Key segment trends
  • 4.2 On-premise
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Web-based
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Cloud-based
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Artificial Intelligence In Epidemiology Market, By Application

  • 5.1 Key segment trends
  • 5.2 Infection Prediction & Forecasting
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Disease & Syndromic Surveillance
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Monitoring Population Health & Incidence/Prevalence
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Artificial Intelligence In Epidemiology Market, By End-Use

  • 6.1 Key segment trends
  • 6.2 Government & State Agencies
    • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.3 Research Labs
    • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.4 Pharmaceutical & Biotechnology Companies
    • 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.5 Healthcare Providers
    • 6.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Artificial Intelligence In Epidemiology Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.2.2 Market size, by deployment, 2017 - 2030 (USD Million)
    • 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.3.2 Market size, by deployment, 2017 - 2030 (USD Million)
    • 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.4.2 Market size, by deployment, 2017 - 2030 (USD Million)
    • 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.5.2 Market size, by deployment, 2017 - 2030 (USD Million)
    • 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.6.2 Market size, by deployment, 2017 - 2030 (USD Million)
    • 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by deployment, 2017 - 2030 (USD Million)
      • 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2021
  • 8.2 Cerner Corporation
    • 8.2.1 Business Overview
    • 8.2.2 Financial Data
    • 8.2.3 Product Landscape
    • 8.2.4 Strategic Outlook
    • 8.2.5 SWOT Analysis
  • 8.3 Cognizant
    • 8.3.1 Business Overview
    • 8.3.2 Financial Data
    • 8.3.3 Product Landscape
    • 8.3.4 Strategic Outlook
    • 8.3.5 SWOT Analysis
  • 8.4 eClinicalWorks, Inc.
    • 8.4.1 Business Overview
    • 8.4.2 Financial Data
    • 8.4.3 Product Landscape
    • 8.4.4 Strategic Outlook
    • 8.4.5 SWOT Analysis
  • 8.5 Epic Systems Corporation
    • 8.5.1 Business Overview
    • 8.5.2 Financial Data
    • 8.5.3 Product Landscape
    • 8.5.4 Strategic Outlook
    • 8.5.5 SWOT Analysis
  • 8.6 Alphabet, Inc.
    • 8.6.1 Business Overview
    • 8.6.2 Financial Data
    • 8.6.3 Product Landscape
    • 8.6.4 Strategic Outlook
    • 8.6.5 SWOT Analysis
  • 8.7 Intel Corporation
    • 8.7.1 Business Overview
    • 8.7.2 Financial Data
    • 8.7.3 Product Landscape
    • 8.7.4 Strategic Outlook
    • 8.7.5 SWOT Analysis
  • 8.8 Microsoft Corporation
    • 8.8.1 Business Overview
    • 8.8.2 Financial Data
    • 8.8.3 Product Landscape
    • 8.8.4 Strategic Outlook
    • 8.8.5 SWOT Analysis
  • 8.9 Meditech
    • 8.9.1 Business Overview
    • 8.9.2 Financial Data
    • 8.9.3 Product Landscape
    • 8.9.4 Strategic Outlook
    • 8.9.5 SWOT Analysis
  • 8.10 Predixion Healthcare (Jvion LLC)
    • 8.10.1 Business Overview
    • 8.10.2 Financial Data
    • 8.10.3 Product Landscape
    • 8.10.4 Strategic Outlook
    • 8.10.5 SWOT Analysis
  • 8.11 Komodo Health
    • 8.11.1 Business Overview
    • 8.11.2 Financial Data
    • 8.11.3 Product Landscape
    • 8.11.4 Strategic Outlook
    • 8.11.5 SWOT Analysis
  • 8.12 Siemens Healthineers
    • 8.12.1 Business Overview
    • 8.12.2 Financial Data
    • 8.12.3 Product Landscape
    • 8.12.4 Strategic Outlook
    • 8.12.5 SWOT Analysis
  • 8.13 Bayer Healthcare
    • 8.13.1 Business Overview
    • 8.13.2 Financial Data
    • 8.13.3 Product Landscape
    • 8.13.4 Strategic Outlook
    • 8.13.5 SWOT Analysis
  • 8.14 Cardiolyse
    • 8.14.1 Business Overview
    • 8.14.2 Financial Data
    • 8.14.3 Product Landscape
    • 8.14.4 Strategic Outlook
    • 8.14.5 SWOT Analysis
  • 8.15 Artificial Intelligence in Medical Epidemiology (AIME)
    • 8.15.1 Business Overview
    • 8.15.2 Financial Data
    • 8.15.3 Product Landscape
    • 8.15.4 Strategic Outlook
    • 8.15.5 SWOT Analysis
  • 8.16 SAS Institute
    • 8.16.1 Business Overview
    • 8.16.2 Financial Data
    • 8.16.3 Product Landscape
    • 8.16.4 Strategic Outlook
    • 8.16.5 SWOT Analysis